StonvexLoading…
StonvexStonvexStonvexCore line items from DXPE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $521.66M | $2.02B | $1.49B | $975.25M |
Operating Income | $42.47M | $176.87M | $130.20M | $86.50M |
Net Income | $19.98M | $88.68M | $65.83M | $23.61M |
EPS (Diluted) | $1.22 | $5.37 | $3.98 | $2.67 |
Total Assets | $1.72B | $1.69B | $1.44B | $1.41B |
Total Liabilities | $1.21B | $1.19B | $956.12M | $944.30M |
Cash & Equivalents | $213.38M | $303.78M | $123.83M | $112.93M |
Free Cash Flow OCF − CapEx | $26.27M | $53.98M | $19.50M | $-8.64M |
Shares Outstanding | 15.51M | 15.51M | 15.68M | 15.69M |